Breeze Meds vs Noom Med: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Noom Med beats Breeze Meds overall, scoring 7.4/10 vs 7.3/10. Noom Med is more affordable at $99/mo vs $199/mo. Choose Breeze Meds for users who want a straightforward compounded glp-1 program wi. Choose Noom Med for users who want a tiered entry into glp-1 care — from $99/mo .

A side-by-side comparison of Breeze Meds and Noom Med covering pricing, scores, medication types, insurance, and more to help you decide.

Breeze Meds

#34 of 48

7.3/10

Compounded GLP-1 provider focused on fast shipping and a no-fuss enrollment process.

Visit Breeze Meds

Higher Rated

Noom Med

#28 of 48

7.4/10

Noom restructured Noom Med in 2026 into 3 tiers: $69/mo branded telehealth (med out-of-pocket), $99-149/mo Microdose GLP-1Rx (low-dose + biomarker monitoring), and the Full GLP-1Rx program ($149 intro → $349/mo on 12-week subscription). Coaching app included at every tier.

Visit Noom Med

Feature	Breeze Meds	Noom Med
Our Score	7.3/10	7.4/10
Starting Price	$199/mo	$99/mo
Medication Type	Compounded	Both
Insurance Accepted	No	Yes
Best For	Users who want a straightforward compounded GLP-1 program with fast shipping	Users who want a tiered entry into GLP-1 care — from $99/mo Microdose all-in (low-dose + biomarkers + coaching) up to a full $349/mo medication + coaching program
Ranking	#34	#28

Pros & Cons Compared

Breeze Meds

Pros

+No subscription required — order on demand without recurring billing commitments
+Three formulation options: injectable semaglutide, oral semaglutide tablet, and oral tirzepatide tablet
+FSA/HSA eligible for those with health savings accounts
+Discreet packaging on all shipments

Cons

−Very limited independent reviews and unclear company structure — legitimacy is hard to verify
−Oral options at $299-399/mo are significantly more expensive than injectable alternatives
−Not available in all 50 states — varies by provider licensure in your state

Noom Med

Pros

+Tiered 2026 entry — $69/mo branded telehealth tier lets users start with just medication access and the coaching app
+New Microdose GLP-1Rx program ($99-149/mo) — low-dose GLP-1 + biomarker monitoring for sensitive users
+Insurance accepted for qualifying plans — can significantly reduce out-of-pocket costs on brand-name meds
+Industry-leading behavioral coaching app with years of psychology-based weight loss methodology

Cons

−Tiered pricing creates confusion — $69, $99-149, or $149-349 depending on tier
−Full GLP-1Rx program requires 12-week subscription ($149 intro rate applies only for the first few weeks)
−Medication costs on the $69 tier are out-of-pocket — the low tier price is just the platform
−App coaching still requires real engagement — skip-prone users waste the behavioral value

Our Verdict

Noom Med edges out Breeze Meds with a score of 7.4/10 vs 7.3/10. If budget is your priority, Noom Med starts at $99/mo compared to Breeze Meds's $199/mo. Noom Med accepts insurance, which can significantly reduce your out-of-pocket costs. Noom Med offers both brand-name and compounded medications, giving you more flexibility. Choose Breeze Meds if you want: users who want a straightforward compounded glp-1 program with fast shipping. Choose Noom Med if you want: users who want a tiered entry into glp-1 care — from $99/mo microdose all-in (low-dose + biomarkers + coaching) up to a full $349/mo medication + coaching program.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Breeze Meds nor Noom Med feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review